Chiome Bioscience Inc.
JPX: 4583.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Masamichi Koike
- Employees
- 47
- Headquarters
- Tokyo, Japan
- IPO year
- 2011
- Market cap
- ¥7B
- Website
- https://www.chiome.co.jp
Loading 4583…
Loading profile data…Frequently asked questions about 4583
What does Chiome Bioscience Inc. (4583.T) do?
Chiome Bioscience Inc. engages in the research and development of drug discovery technology platforms worldwide. The company operates through two segments, Drug Discovery Business and Drug Discovery Support Business. It offers ADLib System, a monoclonal antibody generating system for drug discovery and development; and Human ADLib System, a chic...
Where does 4583.T trade?
Chiome Bioscience Inc. (4583.T) trades on the Tokyo Stock Exchange.
What sector is 4583.T in?
Chiome Bioscience Inc. (4583.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Chiome Bioscience Inc.?
Masamichi Koike is the chief executive officer of Chiome Bioscience Inc. (4583.T).
Where is Chiome Bioscience Inc. headquartered?
Chiome Bioscience Inc. is headquartered in Japan.
Does 4583.T pay a dividend?
Chiome Bioscience Inc. (4583.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4583.T go public?
Chiome Bioscience Inc. (4583.T) completed its initial public offering in 2011.